Overall, the data indicate that in HR-positive breast cancer, hormonal regulation on CCL2 expression might be strongly related to modulation of Twist expression via PI3K/AKT/NF-κB signaling instead of MEK/ERK pathway. Here, TWIST1 is linked to breast carcinoma.